Sell under management: rally pauses, CMF hits new high
Bristol-Myers Squibb dips 0.9%, but money flow climbs to a four-week high
Sell under management: rally pauses, CMF hits new high
Our view last week
Bristol-Myers Squibb is in the sixteenth week of a sell signal, listed on the New York Stock Exchange. The week just closed gained 1.1%, the fourth straight week of technical improvement: the double bottom in the 54 area has already produced an 8% rebound, and the stock is again nearing the threshold that separates the decline from its exhaustion.
This week's summary
Bristol-Myers Squibb stalls after its recent rebound: this week the stock dips 0.9%, but money flow keeps climbing and hits a four-week high. Price is boxed between the daily Kumo ceiling and the pivot-point support, both in the 58/57.5 area — a technical pause in the sell signal's management, not a change of course.
IQS Phase
50
ordinary
Signal Strength
10
decline fading out
Sizing
MINIMUM
Ranking
#73 / 137
US stocks
Trade P&L %
-0.17%
from signal to today
restricted Platinum content